99 related articles for article (PubMed ID: 21628755)
1. [Test and programme sensitivities of screening for colorectal cancer in Reggio Emilia].
Campari C; Sassatelli R; Paterlini L; Camellini L; Menozzi P; Cattani A
Epidemiol Prev; 2011; 35(2):118-24. PubMed ID: 21628755
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.
Castiglione G; Visioli CB; Ciatto S; Grazzini G; Bonanomi AG; Rubeca T; Mantellini P; Zappa M
Br J Cancer; 2007 Jun; 96(11):1750-4. PubMed ID: 17453007
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
4. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
[TBL] [Abstract][Full Text] [Related]
5. Impact of Screening Program on Incidence of Colorectal Cancer: A Cohort Study in Italy.
Giorgi Rossi P; Vicentini M; Sacchettini C; Di Felice E; Caroli S; Ferrari F; Mangone L; Pezzarossi A; Roncaglia F; Campari C; Sassatelli R; Sacchero R; Sereni G; Paterlini L; Zappa M
Am J Gastroenterol; 2015 Sep; 110(9):1359-66. PubMed ID: 26303133
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer in Italy: 2005 survey.
Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
[TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
10. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district.
Grazzini G; Ventura L; Zappa M; Ciatto S; Confortini M; Rapi S; Rubeca T; Visioli CB; Halloran SP
Gut; 2010 Nov; 59(11):1511-5. PubMed ID: 20603498
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
13. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
Green T; Richardson A; Parry S
N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
[TBL] [Abstract][Full Text] [Related]
14. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.
Zorzi M; Fedato C; Grazzini G; Stocco FC; Banovich F; Bortoli A; Cazzola L; Montaguti A; Moretto T; Zappa M; Vettorazzi M
Gut; 2011 Jul; 60(7):944-9. PubMed ID: 21193461
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
16. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
17. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
18. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
[TBL] [Abstract][Full Text] [Related]
19. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience.
Zappa M; Castiglione G; Paci E; Grazzini G; Rubeca T; Turco P; Crocetti E; Ciatto S
Int J Cancer; 2001 Apr; 92(1):151-4. PubMed ID: 11279619
[TBL] [Abstract][Full Text] [Related]
20. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]